[1]Patent:US2014/271540,2014,A1.Locationinpatent:Paragraph0163
Title: Discovery and clinical introduction of first-in-class imipridone ONC201.
Journal: Oncotarget 20161108
Title: Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects.
Journal: Science translational medicine 20130206
Title: Xin D, et al. Development of a 13C NMR Chemical Shift Prediction Procedure Using B3LYP/cc-pVDZ andEmpirically Derived Systematic Error Correction Terms: A Computational Small MoleculeStructure Elucidation Method. J Org Chem. 2017 May 19;82(10):5135-5145.
